Retractable (RVP) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$33.9M

Revenue (quarter)

$7.2M

Revenue growth (year over year)

−31.07%

Gross profit (trailing twelve months)

−$491,509.00

Gross margin

−1.45%

Net income (trailing twelve months)

−$3.4M

Net income (quarter)

$2.8M

Net income growth (year over year)

+3336.24%

Net margin

−9.94%

Return on equity

−4.82%

EPS (trailing twelve months)

−$0.12

Book value per share

$2.43

P/E (trailing twelve months)

—

Price to book

0.28

Debt to assets

48.58%

Payout ratio

45.57%

Dividend yield

—

Company profile

Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.

• Is Retractable (RVP) profitable?

  No. Retractable reported a net loss of $3.4M over the trailing twelve months.

• How much revenue does Retractable (RVP) make?

  Retractable generated $33.9M in revenue over the trailing twelve months, down 31.07% year over year.

• How do I buy stock in Retractable (RVP)?

  RVP trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.